Abstract.
Coagulation factor VIIa (FVIIa) is an atypical member of the trypsin family of serine proteases. It fails to attain spontaneously its catalytically competent conformation and requires its protein cofactor tissue factor (TF) to accomplish this. Over a number of years, this unique behaviour of FVIIa has prompted investigations of the TF-induced activation mechanism and the zymogenicity determinants in factor VIIa. Factor VIIa has gained additional interest in the past decade because of its development into a clinically useful haemostatic agent. Here, we present an overview of the current knowledge about the TF-induced allosteric activation of FVIIa and the various molecular approaches to enhance the intrinsic activity and efficacy of FVIIa.
Similar content being viewed by others
Author information
Authors and Affiliations
Corresponding author
Additional information
Received 18 October 2007; received after revision 12 November 2007; accepted 14 November 2007
Rights and permissions
About this article
Cite this article
Olsen, O.H., Persson, E. Cofactor-induced and mutational activity enhancement of coagulation factor VIIa. Cell. Mol. Life Sci. 65, 953–963 (2008). https://doi.org/10.1007/s00018-007-7480-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00018-007-7480-5